Results in Figure 6 demonstrate that treatment of ECVs from LMP-transfected cells with both LDN and LDN-POx inhibitors resulted in reduced ECV-mediated transfer of LMP1 to the LMP1-negative carcinoma cells (Figure 6B). The gene discussed is PDLIM7; the disease is carcinoma.